Premium Nahrungsergänzungsmittel | artgerecht

L00 Staphylococcal Scalded Skin Syndrome

L00 is the ICD-10 code for Staphylococcal Scalded Skin Syndrome (SSSS), a severe skin condition caused by staphylococcal toxins, primarily affecting newborns and infants.

Regular tips about health Regular tips about health

Things worth knowing about "L00"

L00 is the ICD-10 code for Staphylococcal Scalded Skin Syndrome (SSSS), a severe skin condition caused by staphylococcal toxins, primarily affecting newborns and infants.

What is L00 (Staphylococcal Scalded Skin Syndrome)?

L00 is the official ICD-10 code for Staphylococcal Scalded Skin Syndrome (SSSS), also known as Dermatitis exfoliativa neonatorum or Ritter disease. It is a potentially life-threatening skin disorder triggered by toxins produced by specific strains of Staphylococcus aureus (phage group II). These toxins cause widespread peeling of the upper skin layers, giving the skin an appearance similar to scalding or burns.

Causes

SSSS is caused by exfoliative toxins (ET-A and ET-B) secreted by certain strains of Staphylococcus aureus. These toxins target desmoglein 1, a protein responsible for maintaining the cohesion of cells in the superficial skin layer (stratum granulosum). Once this protein is disrupted, large areas of skin separate and peel off.

Primary infection sites: conjunctiva, umbilicus, pharynx, urinary tract
Bacteria do not need to be present at the site of skin damage
Most at risk: infants and children under 5 years old, and immunocompromised adults

Symptoms

The disease typically begins at a primary infection focus (e.g., conjunctivitis or umbilical infection) and progresses rapidly:

Early phase: Redness, irritability, fever, and painful skin
Progressive phase: Formation of flaccid blisters that rupture quickly
Exfoliation phase: Large-scale skin peeling resembling a second-degree burn
Positive Nikolsky sign: Gentle lateral pressure on apparently healthy skin causes it to slip and peel
Mucous membranes are generally not affected (an important distinction from Stevens-Johnson Syndrome)

Diagnosis

Diagnosis is primarily clinical, based on the characteristic skin findings. The following investigations may support confirmation and differentiation:

Swabs from infection foci (conjunctiva, nose, throat, umbilicus) for bacterial identification
Blood and urine cultures to exclude sepsis
Skin biopsy: reveals characteristic subcorneal splitting in the superficial epidermis
Differential diagnoses: Toxic Epidermal Necrolysis (TEN), bullous pemphigoid, thermal burns

Treatment

Treatment of SSSS typically requires hospital admission, often in an intensive care unit for infants:

Antibiotics: Intravenous penicillinase-resistant penicillins (e.g., flucloxacillin) or cephalosporins; vancomycin if MRSA is suspected
Supportive care: Fluid replacement, electrolyte balance, and pain management
Wound care: Gentle skin care, sterile dressings, prevention of dehydration
Prognosis: Good in children with prompt treatment; mortality below 5% in children; significantly higher in adults (up to 60% in immunosuppressed patients)

References

Wolff K., Johnson R.A., Saavedra A.P. - Fitzpatrick's Color Atlas and Synopsis of Clinical Dermatology, 8th Edition, McGraw-Hill Education, 2017.
Patel G.K., Finlay A.Y. - Staphylococcal scalded skin syndrome: diagnosis and management. American Journal of Clinical Dermatology, 2003; 4(3): 165-175.
World Health Organization (WHO) - ICD-10 Version 2019, Code L00: Staphylococcal scalded skin syndrome. https://icd.who.int/browse10/2019/en#/L00

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.